LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China
· Delayed Price · Currency is CNY 19.26
+0.97 (5.30%)
Apr 1, 2025, 2:45 PM CST
SHA:603883 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 22,479 | 22,288 | 20,055 | 15,579 | 13,867 | 11,586 | Upgrade
|
| Other Revenue | 149.26 | 149.26 | 120.29 | 117.11 | 99.9 | 77.53 | Upgrade
|
| Revenue | 22,628 | 22,437 | 20,176 | 15,696 | 13,967 | 11,663 | Upgrade
|
| Revenue Growth (YoY) | 0.83% | 11.21% | 28.54% | 12.38% | 19.75% | 23.14% | Upgrade
|
| Cost of Revenue | 15,065 | 15,157 | 13,751 | 10,659 | 9,506 | 7,751 | Upgrade
|
| Gross Profit | 7,563 | 7,280 | 6,425 | 5,037 | 4,461 | 3,912 | Upgrade
|
| Selling, General & Admin | 6,098 | 5,753 | 5,005 | 3,990 | 3,483 | 3,069 | Upgrade
|
| Research & Development | 2.46 | 2.51 | 2.23 | - | 0.15 | 1.36 | Upgrade
|
| Other Operating Expenses | 51.71 | 46.21 | 38.51 | 14.95 | 43.66 | 48.13 | Upgrade
|
| Operating Expenses | 6,154 | 5,811 | 5,053 | 4,010 | 3,536 | 3,124 | Upgrade
|
| Operating Income | 1,409 | 1,469 | 1,371 | 1,027 | 924.58 | 788.55 | Upgrade
|
| Interest Expense | -184.47 | -185.6 | -232.14 | -192.13 | -58.49 | -57.95 | Upgrade
|
| Interest & Investment Income | 89.45 | 93.87 | 51.35 | 37.14 | 20.77 | 14.31 | Upgrade
|
| Currency Exchange Gain (Loss) | -5.22 | -5.22 | -16.91 | 4.8 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -19.27 | -14.61 | -13.4 | -14.44 | -27.93 | -18.13 | Upgrade
|
| EBT Excluding Unusual Items | 1,289 | 1,357 | 1,160 | 861.9 | 858.93 | 726.77 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.5 | -1.5 | 5.77 | 10.47 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -53.81 | 5.51 | 1.44 | 4.66 | -1.43 | -0.98 | Upgrade
|
| Asset Writedown | 7.79 | - | - | - | - | -0.18 | Upgrade
|
| Other Unusual Items | 41.16 | 46.69 | 40.21 | 84.95 | 99.37 | 44.77 | Upgrade
|
| Pretax Income | 1,283 | 1,408 | 1,208 | 961.99 | 956.86 | 770.38 | Upgrade
|
| Income Tax Expense | 269.96 | 284.27 | 231.37 | 175.26 | 192.38 | 155.4 | Upgrade
|
| Earnings From Continuing Operations | 1,013 | 1,124 | 976.24 | 786.73 | 764.48 | 614.98 | Upgrade
|
| Minority Interest in Earnings | -170.55 | -194.54 | -191.28 | -117.49 | -143.39 | -106.27 | Upgrade
|
| Net Income | 842.61 | 929.02 | 784.96 | 669.24 | 621.09 | 508.71 | Upgrade
|
| Net Income to Common | 842.61 | 929.02 | 784.96 | 669.24 | 621.09 | 508.71 | Upgrade
|
| Net Income Growth | -5.53% | 18.35% | 17.29% | 7.75% | 22.09% | 16.93% | Upgrade
|
| Shares Outstanding (Basic) | 757 | 760 | 750 | 707 | 682 | 677 | Upgrade
|
| Shares Outstanding (Diluted) | 757 | 760 | 750 | 707 | 691 | 682 | Upgrade
|
| Shares Change (YoY) | 0.17% | 1.23% | 6.08% | 2.42% | 1.21% | 1.43% | Upgrade
|
| EPS (Basic) | 1.11 | 1.22 | 1.05 | 0.95 | 0.91 | 0.75 | Upgrade
|
| EPS (Diluted) | 1.11 | 1.22 | 1.05 | 0.95 | 0.90 | 0.75 | Upgrade
|
| EPS Growth | -5.69% | 16.91% | 10.57% | 5.20% | 20.63% | 15.29% | Upgrade
|
| Free Cash Flow | 1,855 | 2,109 | 2,006 | 1,820 | 1,053 | 606.13 | Upgrade
|
| Free Cash Flow Per Share | 2.45 | 2.78 | 2.67 | 2.57 | 1.52 | 0.89 | Upgrade
|
| Dividend Per Share | 0.838 | 0.508 | 0.385 | 0.296 | 0.207 | 0.177 | Upgrade
|
| Dividend Growth | 117.99% | 32.01% | 30.02% | 42.83% | 16.68% | -16.00% | Upgrade
|
| Gross Margin | 33.42% | 32.45% | 31.84% | 32.09% | 31.94% | 33.54% | Upgrade
|
| Operating Margin | 6.23% | 6.55% | 6.80% | 6.54% | 6.62% | 6.76% | Upgrade
|
| Profit Margin | 3.72% | 4.14% | 3.89% | 4.26% | 4.45% | 4.36% | Upgrade
|
| Free Cash Flow Margin | 8.20% | 9.40% | 9.94% | 11.59% | 7.54% | 5.20% | Upgrade
|
| EBITDA | 1,627 | 1,662 | 1,533 | 1,162 | 1,037 | 883.62 | Upgrade
|
| EBITDA Margin | 7.19% | 7.41% | 7.60% | 7.41% | 7.42% | 7.58% | Upgrade
|
| D&A For EBITDA | 217.55 | 193.69 | 161.87 | 135.67 | 112.02 | 95.07 | Upgrade
|
| EBIT | 1,409 | 1,469 | 1,371 | 1,027 | 924.58 | 788.55 | Upgrade
|
| EBIT Margin | 6.23% | 6.55% | 6.80% | 6.54% | 6.62% | 6.76% | Upgrade
|
| Effective Tax Rate | 21.04% | 20.19% | 19.16% | 18.22% | 20.11% | 20.17% | Upgrade
|
| Revenue as Reported | 22,628 | 22,437 | 20,176 | 15,696 | 13,967 | 11,663 | Upgrade
|
| Advertising Expenses | - | 117.99 | 94.5 | 109.84 | 103.68 | 103.67 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.